UK Pharmaceutical Logistics Market Size
| Study Period | 2020 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2020 - 2022 |
| CAGR | 4.50 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
UK Pharmaceutical Logistics Market Analysis
The United Kingdom Pharmaceutical Logistics Market is valued at USD 7.5 Billion and is expected to register a CAGR of 4.5% during the forecast period. Due to Covid-19, the pharmaceutical sector experienced terrible, unheard-of transportation delays. As a result, our strategy has changed, giving ample time for both planning and preparation.
- In the United Kingdom, the pharmaceutical sector is a significant player. Pharmaceutical wholesalers in the UK had annual revenue of close to 55 billion British pounds in 2020. The pharmaceutical market in the United Kingdom ranks in the top 10 national markets in the world, accounting for about 2.6 per cent of the industry.
- AstraZeneca, situated in Cambridge, and GlaxoSmithKline, based in London, are the two leaders in the British pharmaceutical manufacturing sector. Based on market capitalization, GlaxoSmithKline held the top spot for a while among UK pharmaceutical firms. Even yet, AstraZeneca saw a considerable increase in sales as a result of working with an Oxford University team to create the COVID-19 vaccine. AstraZeneca was said to have a market capitalization of over 170 billion British pounds as of November 2022.
- Pharmaceutical producers pay more attention to the sensitivity and quality of their products. The demand for temperature-controlled transportation and warehousing is increased by variables including the development of sophisticated biological medicines and the dispatch of hormone treatments, vaccinations, and complex proteins that require cold chain enhancements.
- Additionally, the demand for temperature-controlled logistics of pharmaceutical products and medical devices is increasing, which is fueling the growth of the healthcare logistics market. The UK cold chain logistics market is expanding as a result of the rising demand for efficient cold chain logistics services to protect the quality of pharmaceutical products. Additionally, the British government is promoting the use of temperature-controlled warehousing and shipping for pharmaceutical products.
- Since pharmaceutical products such as biologics, vaccines, insulin, and other things need to be kept cold, the CEO of the Association of the British Pharmaceutical Industry, for instance, has requested that the UK government build new cold-chain storages. Therefore, it is projected that growth in the pharmaceutical sector will stimulate growth in the UK logistics business.
UK Pharmaceutical Logistics Market Trends
Increasing Demand for Cold Chain Logistics in the Sector
During the forecast period, the cold chain logistics segment is anticipated to experience significant growth. The ongoing distribution of COVID-19 vaccinations, which necessitates precise temperature-control logistics services to maintain the product's efficacy, is one example of an ambient product with a growing market that can be attributed to this expansion.
In addition, the government's strict restrictions for maintaining precise temperatures for pharmaceutical items that are extremely sensitive to temperature are anticipated to spur segment expansion throughout the course of the projection period.
Telematics is being used more frequently in cold-chain pharmaceutical logistics, which is assisting businesses in improving the productivity, connectivity, and security of cargo. A temperature-controlled environment is necessary for the majority of biological and medicinal products during production and delivery, which helps preserve the medications' potency and quality. As a result, pharmaceutical businesses use systems for cold storage and transportation that are temperature-controlled.
Temperature-controlled or temperature-sensitive products can now be transported with ease thanks to the impressive improvements in supply chain management and integration technology. The rise of supply chain businesses has been fueled by the development of cold chain logistics, which has preserved the product's quality while maintaining the safety of the drugs. The hard chain companies' cold chain logistics services are laying the groundwork for a bright future in the field of temperature-controlled logistics.
On-Demand Delivery Boost Pharmaceutical Logistics Market
The on-demand healthcare sector is fast growing in response to the development of technology as more online home care providers offer on-demand distribution services. Receiving medical care at home increased in popularity throughout the pandemic and continues to do so today because to its increased accessibility and useful treatment alternatives.
Point-of-care diagnostics, online pharmacies, and remote monitoring are three significant growth factors for the years 2022 and beyond. Enterprises in the life sciences and pharmaceutical industries can scale up or down in response to customer needs thanks to the agility and an on-demand distribution model. This kind of service will promote sharing the customized attention each client desires. The pharmaceutical business is increasingly using direct-to-patient delivery methods for both diagnostics and the supply of medications.
Additionally, many companies created subscription programs that allowed everyone to get the right medication at the right time. Industries also aim to establish direct-to-hospital, direct-to-pharmacy, and B2B eCommerce models to ensure timely delivery and order fulfilment. Pharma firms may fully utilise the benefits of these new models with the aid of a B2B integration platform with EDI (electronic data interchange) capabilities. B2B integration solutions enable businesses to interact with their trading partners at numerous points in the supply chain, helping to ensure reliable distribution recycling.
UK Pharmaceutical Logistics Industry Overview
The market is highly fragmented, with many companies across the UK. Some of the top names in this industry include Vision Logistics, Alloga, Alliance Healthcare, Kammac, and DFS Worldwide. To maintain their position in the market, pharmaceutical logistics companies are continuously undertaking strategic initiatives such as mergers and acquisitions. Furthermore, the companies in the market of pharmaceutical logistics are investing in technologies such as telematics, remote sensing and monitoring, and GPS and GIS integration in transporting cargo, thereby providing customers with safe and convenient pharmaceutical logistics services.
UK Pharmaceutical Logistics Market Leaders
-
Vision Logistics
-
Alloga
-
Alliance Healthcare
-
Kammac
-
DFS Worldwide
*Disclaimer: Major Players sorted in no particular order
UK Pharmaceutical Logistics Market News
- November 2022: UPS has acquired Bomi Group, a global healthcare logistics company. With this acquisition, the UPS Healthcare network in Europe and Latin America will gain access to temperature-controlled facilities in 14 countries and over 3,000 highly qualified Bomi Group team members. The acquisition will increase scale and expertise in Europe and Latin America as well as improve end-to-end global healthcare logistics capabilities. For customers of the Bomi Group, joining the UPS team will result in an even more seamless and intelligent worldwide network. Additionally, the acquisition will be crucial for the delivery of pharmaceutical and biologic treatments, which increasingly call for time- and temperature-sensitive logistics.
- March 2022: A portfolio firm of Novo Holdings and a clinical-stage biotechnology company, Syndesi Therapeutics SA, have been acquired by AbbVie. With the acquisition, AbbVie will have access to Syndesi's portfolio of cutting-edge SV2A modulators, including its flagship drug SDI-118. AbbVie will provide an upfront payment of USD 130 million to the shareholders of Syndesi, with the possibility for additional contingent payments of up to USD 870 million based on the accomplishment of specific predetermined milestones.The acquisition expands AbbVie's portfolio of neuroscience products.
Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS AND DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.3 Market Restraints
- 4.4 Value Chain / Supply Chain Analysis
-
4.5 Industry Attractiveness - Porters Five Force's Analysis
- 4.5.1 Threat of New Entrants
- 4.5.2 Bargaining Power of Buyers/Consumers
- 4.5.3 Bargaining Power of Suppliers
- 4.5.4 Threat of Substitute Products
- 4.5.5 Intensity of Competitive Rivalry
- 4.6 Insights Into The 3PL Market in United Kingdom
- 4.7 Impact of COVID-19 on the Market
5. MARKET SEGMENTATION
-
5.1 By Product
- 5.1.1 Generic Drugs
- 5.1.2 Branded Drugs
-
5.2 By Operation
- 5.2.1 Cold Chain Transport
- 5.2.2 Non-cold Chain Transport
-
5.3 By Application
- 5.3.1 Biopharma
- 5.3.2 Chemical Pharma
-
5.4 By Transportation
- 5.4.1 Airways
- 5.4.2 Railways
- 5.4.3 Roadways
- 5.4.4 Seaways
6. COMPETITIVE LANDSCAPE
- 6.1 Market Overview
-
6.2 Company Profiles
- 6.2.1 Vision Logistics
- 6.2.2 Alloga
- 6.2.3 Alliance Healthcare
- 6.2.4 Kammac
- 6.2.5 DFS Worldwide
- 6.2.6 Forest Freight
- 6.2.7 Cool Cargo
- 6.2.8 Dynamic Medical Logistics
- 6.2.9 CDL Logistics Group
- 6.2.10 Circle Express UK*
- *List Not Exhaustive
7. FUTURE OF THE MARKET
** Subject To AvailablityUK Pharmaceutical Logistics Industry Segmentation
Pharmaceutical logistics involves manufacturing, processing, and shipping materials and resources. Pharmaceutical Logistics companies also undertake activities related to handling finished products for customers.
Transporting healthcare products by different modes needs the establishment of complex logistical methods to maintain a pharmaceutical shipment's integrity. It requires specific equipment, storage facilities, harmonized handling procedures, and strong cooperation among the cold chain partners. For pharmaceutical companies, logistics companies play a vital role in their functioning.
The United Kingdom Pharmaceutical Logistics market is segmented By Product (Generic Drugs, Branded Drugs), By Mode of Operation (Cold Chain Transport, Non-Cold Chain Transport), By Application (Bio Pharma, Chemical Pharma), By Mode Of Transport (Air, Rail, Road, and Sea) The report offers market size and forecast for United Kingdom Pharmaceutical Logistics Market in value (USD billion) for all the above segments.
| By Product | Generic Drugs |
| Branded Drugs | |
| By Operation | Cold Chain Transport |
| Non-cold Chain Transport | |
| By Application | Biopharma |
| Chemical Pharma | |
| By Transportation | Airways |
| Railways | |
| Roadways | |
| Seaways |
Frequently Asked Questions
What is the current UK Pharmaceutical Logistics Market size?
The UK Pharmaceutical Logistics Market is projected to register a CAGR of 4.5% during the forecast period (2024-2029)
Who are the key players in UK Pharmaceutical Logistics Market ?
Vision Logistics, Alloga, Alliance Healthcare, Kammac and DFS Worldwide are the major companies operating in the UK Pharmaceutical Logistics Market .
What years does this UK Pharmaceutical Logistics Market cover?
The report covers the UK Pharmaceutical Logistics Market historical market size for years: 2020, 2021, 2022 and 2023. The report also forecasts the UK Pharmaceutical Logistics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
UK Pharmaceutical Logistics Market Industry Report
Statistics for the 2024 UK Pharmaceutical Logistics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. UK Pharmaceutical Logistics analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
